Burning Rock Biotech 

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$148,554
$133,082
$126,022
$128,644
Gross Profit
108,103
97,401
89,422
91,846
EBITDA
-15,179
-38,589
Net Income
-9,702
-13,500
-81,294
-35,745
Net Change In Cash
148,554
133,082
126,022
128,644
Free Cash Flow
-44,349
13,085
13,085
-30,278
Cash
452,721
495,145
519,849
497,969
Basic Shares
107,665
1,076
107,613
1,032

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$515,822
$537,435
$563,238
$507,862
Gross Profit
362,400
363,227
380,039
364,146
EBITDA
-270,232
-517,901
-856,311
-746,496
EBIT
-322,432
-651,301
-980,407
-794,262
Net Income
-346,626
-653,689
-971,233
-796,697
Net Change In Cash
515,822
537,435
563,238
507,862
Free Cash Flow
-98,238
-265,167
-518,839
-691,334
Cash
519,849
615,096
905,451
1,431,317
Basic Shares
1,029
1,024
1,039
1,042

Earnings Calls

Quarter EPS
2025-06-30
-$0.90
2025-03-31
-$1.25
2024-12-31
-$7.87
2024-09-30
-$0.48